Evidence map›Paper›PMID 39900650›Full record

ArticleCommunications medicine2025

Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer.

Anne Meunier, Javier Alejandro Hernández-Castro, Nicholas Chahley, Laudine Communal, Sara Kheireddine, Newsha Koushki, Nadia Davoudvandi, Sara Al Habyan, Benjamin Péant, Anthoula Lazaris and 7 more

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anne MeunierBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Javier Alejandro Hernández-CastroBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Nicholas ChahleyBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Laudine CommunalInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, H2X 0A9, Canada.
Sara KheireddineBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.ORCID http://orcid.org/0000-0002-1755-200X
Newsha KoushkiBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Nadia DavoudvandiBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Sara Al HabyanRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, H3A 1A3, Canada.
Benjamin PéantInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, H2X 0A9, Canada.
Anthoula LazarisCancer Research Program, The Research Institute of McGill University Health Center, Montreal, QC, H4A 3J1, Canada.ORCID http://orcid.org/0000-0002-2173-7891
Andy NgBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.ORCID http://orcid.org/0000-0003-3257-0801
Teodor VeresBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada.
Luke McCaffreyRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, H3A 1A3, Canada.
Diane ProvencherInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, H2X 0A9, Canada.
Peter MetrakosCancer Research Program, The Research Institute of McGill University Health Center, Montreal, QC, H4A 3J1, Canada.
Anne-Marie Mes-MassonInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, H2X 0A9, Canada.ORCID http://orcid.org/0000-0002-6498-266X
David JunckerBiomedical Engineering Department, McGill University, Montreal, QC, H3A 2B4, Canada. david.juncker@mcgill.ca.ORCID http://orcid.org/0000-0002-7313-1162

Funding

Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) 446671-13
6 · The paper itself

Abstract

backgroundCirculating tumor cells (CTCs) are rare (a few cells per milliliter of blood) and mostly isolated as single-cell CTCs (scCTCs). CTC clusters (cCTCs), even rarer, are of growing interest, notably because of their higher metastatic potential, but very difficult to isolate.

methodWe introduce gravity-based microfiltration (GµF) for facile isolation of cCTCs using in-house fabricated microfilters and 3D printed cartridges. Optimal flow rate and pore size for cCTC isolation are determined by GµF of cultured ovarian single cells and cell clusters spiked in healthy blood. We perform GµF of blood from orthotopic ovarian cancer mouse models and characterize the morphological features of scCTCs and cCTCs, and the expression of molecular markers for aggressiveness. Finally, we analyze blood from 17 epithelial ovarian cancer patients with either localized or metastatic disease, and from 13 colorectal cancer liver metastasis patients.

resultsHere, we show that GµF optimized for cell cluster isolation captures cCTCs from blood while minimizing unwanted cluster disaggregation, with ~85% capture efficiency. We detect cCTCs in every patient, with between 2-100+ cells. We find cCTCs represent between 5-30% of all CTC capture events, and 10-80% of the CTCs are clustered; remarkably, in 10 patients, most CTCs are circulating not as scCTCs, but as cCTCs.

conclusionsGµF uncovers the unexpected prevalence and frequency of cCTCs including sometimes very large ones in epithelial ovarian cancer patients, and motivates additional studies to uncover their properties and role in disease progression.

Identifiers

PMID39900650
PMCPMC11790846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.